144 related articles for article (PubMed ID: 3810519)
1. [Microcomputerized data bank of nephrotoxic drugs at the Paris-Saint Antoine Regional Drug Monitoring Center].
Hamel JD; Biour M; Cheymol G
Therapie; 1986; 41(5):327-9. PubMed ID: 3810519
[No Abstract] [Full Text] [Related]
2. [Drug nephrotoxicity. A microcomputerized databank of renal involvement and responsible "nephrotox" drugs].
Hamel JD; Biour M; Cheymol G
Therapie; 1988 May; 43(3):211-7. PubMed ID: 3420569
[No Abstract] [Full Text] [Related]
3. [Advantages of a microcomputer system in researching duplicated reports].
Biour M; Wagniart F; Jablonka J; Hamel JD; Weissenburger J; Cheymol G
Therapie; 1986; 41(5):383-4. PubMed ID: 3810530
[No Abstract] [Full Text] [Related]
4. [Computerized detection of new adverse effects in drug surveillance. A proposal for the periodic use of the French data bank].
Pham E; Ventre JJ; Saddier P; Descotes J; Evreux JC
Therapie; 1988 May; 43(3):235-7. PubMed ID: 3420571
[No Abstract] [Full Text] [Related]
5. [Critical analysis of the adverse effects reported to the Paris-Fernand Widal Drug Monitoring Center in a 2-month period].
Castot A; Carlier P; Lagier G; Elmalem J; Vincens M; Efthymiou M
Therapie; 1986; 41(5):375-7. PubMed ID: 3810528
[No Abstract] [Full Text] [Related]
6. [Drug monitoring].
Royer RJ
Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():11-30. PubMed ID: 4064240
[No Abstract] [Full Text] [Related]
7. [Information centers on undesirable effects of drugs: also on alerting function].
Bégaud B; Péré JC; Tubert P; Barat C; Haramburu F; Albin H
Therapie; 1987; 42(2):231-7. PubMed ID: 3617000
[No Abstract] [Full Text] [Related]
8. [Eighth French Drug Surveillance Seminar. Paris, 23-24 October 1986].
Therapie; 1987; 42(4):331-410. PubMed ID: 3686465
[No Abstract] [Full Text] [Related]
9. Monitoring adverse drug reactions in the postmarketing phase.
Hoigné R; Hottinger S
Pharm Acta Helv; 1988; 63(1):2-12. PubMed ID: 3283774
[No Abstract] [Full Text] [Related]
10. [Microcomputerized data bank of hematotoxic drugs sold in France].
Biour M; Jablonka J; Weissenburger J; Cheymol G
Therapie; 1986; 41(2):129-33. PubMed ID: 3726785
[No Abstract] [Full Text] [Related]
11. [Detection of drug side effects at the Heidelberg Medical Clinic].
Jacubeit T; Drisch D
Verh Dtsch Ges Inn Med; 1989; 95():690-3. PubMed ID: 2603505
[No Abstract] [Full Text] [Related]
12. [30 years' spontaneous recording systems of German physicians--results and experiences].
Kimbel KH
Verh Dtsch Ges Inn Med; 1989; 95():683-6. PubMed ID: 2603503
[No Abstract] [Full Text] [Related]
13. [Drug by drug imputation of adverse effects in drug monitoring. Attempted comparison of different methods].
Lagier G; Vincens M; Lefebure B; Frelon JH
Therapie; 1983; 38(3):295-302. PubMed ID: 6612666
[No Abstract] [Full Text] [Related]
14. Statewide test of a new postmarketing drug surveillance system.
Fisher S; Bryant SG; Solovitz BL; Kluge RM
Tex Med; 1987 Aug; 83(8):59-62. PubMed ID: 3660262
[No Abstract] [Full Text] [Related]
15. Measuring adverse drug reactions in a postmarketing surveillance system.
Fisher S; Bryant SG; Kluge RM
Psychopharmacol Bull; 1986; 22(1):272-7. PubMed ID: 3726073
[No Abstract] [Full Text] [Related]
16. [Necessity and difficulties of quantitative drug monitoring].
Lagier G; Dally S; Vincens M; Castot A
Therapie; 1983; 38(3):319-23. PubMed ID: 6612668
[No Abstract] [Full Text] [Related]
17. [Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid].
Lagier G; Vincens M; Castot A
Therapie; 1983; 38(3):303-18. PubMed ID: 6612667
[No Abstract] [Full Text] [Related]
18. [Comparative organization of drug monitoring in France and 7 European countries].
Vaissere J; de Cremiers F; Auriche M; Juillet Y
Therapie; 1986; 41(5):369-74. PubMed ID: 3810527
[No Abstract] [Full Text] [Related]
19. [Comprehensive detection of severe, potentially life-threatening drug side effects].
Schönhöfer PS; Wessely-Stickel B; Schulte-Sasse H; Werner W
Verh Dtsch Ges Inn Med; 1989; 95():687-90. PubMed ID: 2603504
[No Abstract] [Full Text] [Related]
20. [Assessment of the severity and cost of adverse drug effects recorded at the Paris-Fernand Widal Drug Monitoring Center during 2 monthly periods].
Castot A; Lagier G; Merigot P; de Crémoux P; Efthymiou ML
Therapie; 1987; 42(4):365-7. PubMed ID: 3686469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
